Henk Doude van Troostwijk
Corporate Officer/Principal presso HANSA BIOPHARMA AB
Posizioni attive di Henk Doude van Troostwijk
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HANSA BIOPHARMA AB | Corporate Officer/Principal | 01/06/2019 | - |
Storia della carriera di Henk Doude van Troostwijk
Precedenti posizioni note di Henk Doude van Troostwijk
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Corporate Officer/Principal | - | - |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands. | Corporate Officer/Principal | - | - |
| RAPTOR PHARMACEUTICAL CORP | Corporate Officer/Principal | 15/04/2012 | - |
Formazione di Henk Doude van Troostwijk
| Henley Management College | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Regno Unito | 2 |
| Paesi Bassi | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| Aziende private | 3 |
|---|---|
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Health Technology |
Genzyme Europe BV
Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands. | Health Technology |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
